Feline Dilated Cardiomyopathy

Feline dilated cardiomyopathy (DCM) is a primary myocardial disease characterized by ventricular chamber dilation and systolic dysfunction (reduced contractility) in the absence of other identifiable structural cardiac lesions [4]. It is distinct from the much more prevalent hypertrophic cardiomyopathy (HCM) in cats and, while relatively uncommon today, remains a clinically important condition. Historically, feline DCM was strongly linked to dietary taurine deficiency, and the dramatic reduction in its incidence following routine taurine supplementation of commercial cat foods in the late 1980s confirmed this nutritional association. However, recent reports have highlighted a possible re-emergence of diet-associated DCM—including in cats fed pulse-rich diets with normal taurine levels—alongside non-nutritional causes such as genetic predisposition and endocrine disorders [2][3][5].

Feline DCM is a multifactorial disease, and its causes can be broadly categorized as nutritional, genetic, endocrine, and idiopathic:

Nutritional (Taurine Deficiency)

Taurine is an essential amino acid in cats (unlike most other mammals, cats cannot synthesize taurine in sufficient quantities). Dietary taurine deficiency leads to impaired myocardial cell membrane stability, mitochondrial dysfunction, calcium dysregulation within cardiomyocytes, and ultimately systolic failure with progressive ventricular dilation. The historical epidemic of feline DCM in the 1980s was directly attributed to taurine-deficient commercial diets, and its near-disappearance after mandatory supplementation confirms this causal link.

Diet-Associated DCM with Normal Taurine Levels

More recently, a possible association between pulse-containing diets (e.g., peas, lentils, chickpeas) and DCM has been investigated in both dogs and cats [1][2][3]. A case report described an 11-year-old cat with severe DCM and CHF that had been fed pulse-rich diets, yet had normal plasma and whole blood taurine concentrations [2]. The mechanism by which pulses may contribute to DCM independent of taurine deficiency is not yet fully elucidated but may involve other anti-nutritional factors or alterations in amino acid metabolism [2][3]. A survey and retrospective evaluation of cardiologists found diet may be a relevant factor in a subset of contemporary feline DCM cases [3].

Genetic Predisposition

Evidence from a large cattery study suggests that quantitative genetic factors—operating either independently or interactively with nutritional influences—are involved in feline DCM [8]. Clinically affected cats were found to be significantly more interrelated than control populations from the same colony, pointing to polygenic inheritance [8]. In the broader context of companion animal cardiology, numerous genetic mutations are now recognized as causes of cardiomyopathy, and personalized genomic medicine is being explored as a future management tool [7].

Endocrine and Developmental Causes

DCM has been reported in association with congenital hyposomatotropism (growth hormone deficiency) in a 7-month-old cat, suggesting that hormonal abnormalities affecting myocardial growth and metabolism can precipitate the disease [5].

Secondary/Structural Changes: Endocardial Fibroelastosis (EFE)

DCM may occur concurrently with endocardial fibroelastosis (EFE), a proliferation of fibroelastic fibers in the endocardium. Current evidence suggests EFE is likely a secondary response to myocardial dysfunction rather than a primary disease entity [4]. This has been documented in wild felids as well, including a juvenile Pallas cat [4].

Pathological Mechanism

Regardless of the underlying cause, the final common pathway involves progressive loss of myocardial contractility, ventricular chamber dilation (especially the left ventricle), reduced ejection fraction, elevated ventricular filling pressures, and ultimately pulmonary or systemic venous congestion (CHF). Stasis of blood within dilated cardiac chambers predisposes to intracardiac thrombus formation and subsequent aortic thromboembolism [2][3].

Clinical Examination

Physical examination may reveal tachycardia or bradycardia, a cardiac murmur or gallop rhythm (S3), muffled heart and/or lung sounds (from effusions), weak femoral pulses, hypothermia, and signs of respiratory distress [3].

Echocardiography (Gold Standard)

Echocardiography is the definitive diagnostic tool for DCM. Key findings include:

• ·Increased left ventricular internal diameter at end-diastole (LVIDd) and end-systole (LVIDs)
• ·Reduced fractional shortening (FS < 25–29% is generally considered abnormal in cats)
• ·Reduced ejection fraction
• ·Left atrial enlargement (increased LA:Ao ratio)
• ·Possible intracardiac thrombus visualization [2][3][4]

For reference, in meerkats (a related DCM model species), DCM was defined using LVIDd > 1.30 cm as a threshold criterion [6], illustrating how standardized echocardiographic reference ranges are species-specific.

Thoracic Radiography

Radiographs typically show cardiomegaly, pleural effusion, pulmonary venous congestion, or pulmonary edema consistent with CHF [3].

Electrocardiography (ECG)

May demonstrate atrial or ventricular arrhythmias, conduction disturbances, or signs of chamber enlargement.

Laboratory Investigations

Blood and urine testing are essential to rule out concurrent disease and identify predisposing nutritional deficiencies:

• ·Taurine levels: Plasma taurine (normal > 40–60 nmol/mL) and whole blood taurine (normal > 200 nmol/mL) should be measured. Normal taurine does not fully exclude diet-associated DCM [2][3]
• ·Complete Blood Count (CBC):
  • ·HCT (Hematocrit): May be low (anemia of chronic disease) or elevated if dehydrated
  • ·WBC: Usually within normal limits unless secondary infection is present
  • ·PLT (Platelets): Thrombocytopenia may occur with ATE or DIC
• ·Serum Biochemistry:
  • ·BUN / CREA (Kidney function): Azotemia may be pre-renal (low cardiac output) or indicate concurrent renal disease, which significantly impacts treatment decisions (especially diuretic dosing) [2]
  • ·ALT (Alanine aminotransferase): May be mildly elevated due to hepatic congestion from right-sided CHF
  • ·TBIL (Total bilirubin): Can be mildly elevated with hepatic congestion
  • ·ALB (Albumin): Low albumin (hypoalbuminemia) can contribute to effusion formation and worsen prognosis
  • ·GLOB (Globulins): May vary; important to assess total protein status
  • ·Electrolytes (Na⁺, K⁺): Hypokalemia and hyponatremia can complicate diuretic therapy; hyperkalemia may occur with concurrent renal failure
  • ·Glucose: Hypoglycemia was noted in a juvenile DCM case associated with hyposomatotropism [5]
  • ·IGF-1 (Insulin-like Growth Factor 1): Low in hyposomatotropism-associated DCM [5]
• ·Cardiac Biomarkers:
  • ·NT-proBNP (N-terminal pro-B-type natriuretic peptide): Elevated in cats with significant myocardial stress and CHF; useful as a screening and monitoring tool [6]
  • ·Cardiac troponin I (cTnI): Elevated with myocardial injury

Dietary History

A thorough dietary history is critical and should include brand, formulation, and specific ingredients (particularly pulse content) [2][3]. Cardiologists have increasingly incorporated diet questionnaires into DCM workups.

Treatment of feline DCM targets relief of congestive signs, improvement of cardiac output, management of arrhythmias, thromboembolism prevention, and addressing the underlying cause where possible.

Nutritional Intervention

• ·Taurine supplementation: All cats with DCM should receive taurine supplementation (typically 250–500 mg orally twice daily) regardless of measured taurine levels, as laboratory values may not reflect myocardial taurine stores
• ·Dietary change: Pulse-containing or "boutique" diets should be discontinued and replaced with established commercial cat foods with known nutritional profiles [2][3]. In the reported pulse-diet case, the cat's clinical signs improved following dietary change alone, without taurine supplementation [2]

Management of Congestive Heart Failure

• ·Furosemide: The primary diuretic for relief of pulmonary edema and pleural effusion; dose adjusted based on renal function [2][3]
• ·Thoracocentesis: Indicated for significant pleural effusion causing respiratory distress; provides rapid symptomatic relief
• ·Oxygen therapy: For cats in acute respiratory crisis

Positive Inotropic Support

• ·Pimobendan: A phosphodiesterase inhibitor and calcium sensitizer with positive inotropic and vasodilatory effects; increasingly used in feline DCM analogous to its established role in canine DCM [2][3]. Pimobendan was included in the treatment of the pulse-diet-associated DCM case with positive outcome [2]
• ·Digoxin: Historically used for its positive inotropic and antiarrhythmic effects but now less commonly used due to narrow therapeutic index and availability of pimobendan

Additional Cardiac Medications

• ·ACE inhibitors (e.g., enalapril, benazepril): Used for neurohormonal modulation (RAAS inhibition), preload/afterload reduction, and cardiac remodeling prevention
• ·Beta-blockers (e.g., atenolol): May be used cautiously for rate control in tachyarrhythmias, but must be used carefully given risk of worsening cardiac output in DCM

Thromboembolism Prevention

• ·Clopidogrel: Antiplatelet agent recommended to reduce ATE risk; was included in the treatment protocol for the reported feline DCM case [2]
• ·Aspirin or low-molecular-weight heparin: Alternative or adjunct anticoagulant/antiplatelet strategies may be considered

Monitoring

Regular echocardiographic reassessment, renal function monitoring, and electrolyte checks are essential, particularly after initiating or adjusting diuretics [2][3].

The prognosis for feline DCM varies substantially depending on the underlying etiology, severity of disease at presentation, and response to treatment.

Taurine-Deficiency DCM

Cats with DCM attributable to taurine deficiency historically carry a more favorable prognosis compared to idiopathic DCM, as myocardial function can partially or fully recover with taurine supplementation and appropriate cardiac management over weeks to months.

Diet-Associated DCM (Pulse-Related)

A case report described clinical improvement following diet change and standard cardiac therapy (furosemide, pimobendan, clopidogrel), suggesting that reversibility may be possible in this subtype as well [2]. However, given the small number of reported cases, broad survival statistics are not yet available [2][3].

General Feline DCM Prognosis

• ·A survey of veterinary cardiologists and retrospective case review noted that feline DCM is associated with significant morbidity and mortality, with many cats presenting in CHF at the time of diagnosis [3]
• ·Cats presenting with severe CHF, ATE, or concurrent renal disease carry a guarded to poor prognosis
• ·The short-term mortality in cats presenting in acute CHF is high, with survival measured in days to weeks in the most severe cases, though some cats with reversible causes can survive months to years with treatment [2][3]
• ·Data from canine DCM studies illustrate that diet change in diet-associated DCM can lead to echocardiographic improvement [1], and similar outcomes are anticipated—but not yet quantified—in cats

Important limitation: Comprehensive, peer-reviewed long-term survival statistics specific to feline DCM (including median survival times stratified by cause) are limited in the currently available literature. The studies cited [2][3] represent the most recent data but involve small case numbers. Clinicians should counsel owners on an individualized basis given this uncertainty.

Dietary Management

• ·Taurine-adequate diet: Feed cats only commercial diets that meet AAFCO (Association of American Feed Control Officials) nutrient profiles and have undergone feeding trials. Avoid home-prepared or raw diets unless formulated by a board-certified veterinary nutritionist with taurine supplementation
• ·Avoid pulse-rich diets: Given emerging evidence linking high-pulse diets (peas, lentils, chickpeas) to possible DCM [2][3], it is prudent to avoid foods listing these ingredients prominently, even if taurine supplementation is included
• ·Diet transparency: Choose diets from established manufacturers with a long nutritional research history and transparent ingredient sourcing [1][3]

Genetic and Breeding Considerations

• ·Given evidence of genetic involvement in feline DCM [8], breeding programs in catteries with a known history of DCM should be approached cautiously
• ·Development of genetic screening tools for inherited cardiomyopathies in cats is an evolving field within personalized veterinary medicine [7]

Routine Cardiac Screening

• ·Cats of breeds or from lines with known cardiac disease history should undergo periodic echocardiographic screening
• ·Cardiac biomarker testing (NT-proBNP) may be used as a non-invasive screening tool in at-risk populations [6]

Monitoring at-Risk Cats

• ·Cats with endocrine diseases (e.g., hyposomatotropism, hyperthyroidism) should be monitored for secondary cardiac changes [5]
• ·Cats on novel or non-mainstream diets should have periodic veterinary evaluations including cardiac auscultation

METADATA